CGP 3466B has no effect on disease course of (G93A) mSOD1 transgenic mice

References

• Yoshiyama Y, Yamada T, Asanuma K, Asahi T. Apoptosis related antigen, Le(Y) and nick-end labelling are positive in spinal motor neurons in amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 1994; 88(3): 207–211.
   PubMed Web of Science ®Google Scholar
• Mu X, He J, Anderson DW, Trojanowski JQ, Springer JE. Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons. Ann Neurol 1996; 40(3): 379–386.
   PubMed Web of Science ®Google Scholar
• Martin LJ. Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J Neuropathol Exp Neurol 1999; 58(5): 459–471.
   PubMed Web of Science ®Google Scholar
• Kostic V, Jackson Lewis V, de Bilbao F, Dubois Dauphin M, Przedborski S. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 1997; 277(5325): 559–562.
   PubMed Web of Science ®Google Scholar
• Friedlander RM, Brown RH, Gagliardini V, Wang J, Yuan J. Inhibi- tion of ICE slows ALS in mice. Nature 1997; 388(6637): 31–31.
   PubMed Web of Science ®Google Scholar
• Vukosavic S, Stefanis L, Jackson-Lewis V et al. Delaying caspase activation by Bcl-2: a clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci 2000; 20(24): 9119–9125.
   Google Scholar
• Li M, Ona VO, Guegan C et al. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 2000; 288(5464): 335–339.
   Google Scholar
• Yamashita S, Mita S, Arima T et al. Bcl-2 expression by retrograde transport of adenoviral vectors with Cre- loxP recombination system in motor neurons of mutant SOD1 transgenic mice. Gene Ther 2001; 8(13): 977–986.
   Google Scholar
• Kragten E, Lalande I, Zimmermann K et al. Glyceraldehyde-3- phosphate dehydrogenase, the putative target of the antiapopto- tic compounds CGP 3466 and R-(-)-deprenyl. J Biol Chem 1998; 273(10): 5821–5828.
   Google Scholar
• Paterson IA, Waldmeier P, Boulton AA. CGP3466 and CGP3466B prevent cytosine arabinoside-induced apoptosis in cultures of cerebellar neurons. J Neurochem 1998; 70(suppl1): S11B.
   Google Scholar
• Andringa G, van Oosten RV, Stoof JC, Cools AR. Systemic administration of CGP3466B prevents enzymatic and beha- vioural deficits in 6-OHDA treated rats. Soc Neurosci Abstr 1999; 25: 133.20.
   Google Scholar
• Waldmeier PC, Boulton AA, Cools AR, Kato AC, Tatton WG. Neurorescuing effects of the GAPDH ligand CGP 3466B. J Neural Transm (Suppl) 2000; (60): 197–214.
   Google Scholar
• Sirover MA. New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydro- genase. Biochim Biophys Acta 1999; 1432(2): 159–184.
   PubMed Web of Science ®Google Scholar
• Sawa A, Khan AA, Hester LD, Snyder SH. Glyceraldehyde-3- phosphate dehydrogenase: nuclear translocation participates in neuronal and non-neuronal cell death. Proc Natl Acad Sci USA 1997; 94(21): 11 669–11 674.
   Google Scholar
• Ishitani R, Tanaka M, Sunaga K, Katsube N, Chuang DM. Nuclear localisation of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. Mol Pharmacol 1998; 53(4): 701–707.
   PubMed Web of Science ®Google Scholar
• Saunders PA, Chen RW, Chuang DM. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase isoforms during neuronal apoptosis. J Neurochem 1999; 72(3): 925–932.
   PubMed Web of Science ®Google Scholar
• Carlile GW, Chalmers-Redman RM, Tatton NA, Pong A, Borden KE, Tatton WG. Reduced apoptosis after nerve growth factor and serum withdrawal: conversion of tetrameric glyceraldehyde-3- phosphate dehydrogenase to a dimer. Mol Pharmacol 2000; 57(1): 2–12.
   PubMed Web of Science ®Google Scholar
• Tatton WG, Chalmers-Redman RM, Ju WJ et al. Propargylamines induce antiapoptotic new protein synthesis in serum- and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells. J Pharmacol Exp Ther 2002; 301(2): 753–764.
   Google Scholar
• Huebscher KJ, Lee J, Rovelli G et al. Protein isoaspartyl methyltransferase protects from Bax-induced apoptosis. Gene 1999; 240(2): 333–341.
   Google Scholar
• Sagot Y, Toni N, Perrelet D et al. An orally active anti-apoptotic molecule (CGP 3466B) preserves mitochondria and enhances survival in an animal model of motor neuron disease. Br J Pharmacol 2000; 131(4): 721–728.
   Google Scholar
• Andreassen OA, Dedeoglu A, Friedlich A et al. Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice. Exp Neurol 2001; 168(2): 419–424.
   Google Scholar
• Gurney ME, Pu H, Chiu AY et al. Motor neuron degeneration in mice that express a human Cu/Zn superoxide dismutase mutation. Science 1994; 264(5166): 1772–1775.
   Google Scholar
• Gurney ME, Cutting FB, Zhai P, Andrus PK, Hall ED. Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu/Zn superoxide dismutase. Pathol Biol Paris 1996; 44(1): 51–56.
   PubMedGoogle Scholar
• Barneoud P, Lolivier J, Sanger DJ, Scatton B, Moser P. Quantitative motor assessment in FALS mice: a longitudinal study. Neuroreport 1997; 8(13): 2861–2865.
   PubMed Web of Science ®Google Scholar
• Adams JC. Heavy metal intensification of DAB-based HRP reaction product. J Histochem Cytochem 1981; 29(6): 775.
   PubMed Web of Science ®Google Scholar
• Andringa G, Cools AR. The neuroprotective effects of CGP 3466B in the best in vivo model of Parkinson’s disease, the bilaterally MPTP-treated rhesus monkey. J Neural Transm (Suppl) 2000; (60): 215–225.
   Google Scholar
• Park DS, Morris EJ, Stefanis L et al. Multiple pathways of neuronal death induced by DNA-damaging agents, NGF depriva- tion, and oxidative stress. J Neurosci 1998; 18(3): 830–840.
   Google Scholar
• Berry MD, Boulton AA. Glyceraldehyde-3-phosphate dehydro- genase and apoptosis. J Neurosci Res 2000; 60(2): 150–154.
   PubMed Web of Science ®Google Scholar
• Dastoor Z, Dreyer JL. Potential role of nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase in apoptosis and oxidative stress. J Cell Sci 2001; 114(Pt 9): 1643–1653.
   Web of Science ®Google Scholar
• Raoul C, Estevez AG, Nishimune H et al. Motor neuron death triggered by a specific pathway downstream of Fas potentiation by ALS-linked SOD1 mutations. Neuron 2002; 35(6): 1067–1083.
   Google Scholar
• Dal Canto MC, Gurney ME. A low expressor line of transgenic mice carrying a mutant human Cu/Zn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis. Acta Neuropathol Berl 1997; 93(6): 537–550.
   PubMed Web of Science ®Google Scholar
• Waibel S, Malessa R, Reuter A, Blaugrund E, Ludolph AC. The MAO-inhibitor rasagiline is neuroprotective in ALS. Amyotroph.Lateral.Scler Other Motor Neuron Disord 2002; 3 (suppl 2): 71, p.38.
   Google Scholar
• Kunikowska G, Gallagher I, Glover V, Clow A, Jenner P. Effects of short- and long-term (-)-deprenyl administration on mRNA for copper, zinc- and manganese-superoxide dismutase and glutathione peroxidase in rat brain. Brain Res 2002; 953(1–2): 1–11.
   Google Scholar
• Kuntz C, Kinoshita Y, Beal MF, Donehower LA, Morrison RS. Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis. Exp Neurol 2000; 165(1): 184–190.
   PubMed Web of Science ®Google Scholar
• Prudlo J, Koenig J, Graser J et al. Motor neuron cell death in a mouse model of FALS is not mediated by the p53 cell survival regulator. Brain Res 2000; 879(1–2): 183–187.
   Google Scholar
• de la Monte SM, Sohn YK, Ganju N, Wands JR. P53- and CD95- associated apoptosis in neurodegenerative diseases. Lab Invest 1998; 78(4): 401–411.
   PubMed Web of Science ®Google Scholar
• Waldmeier PC. Prospects for antiapoptotic drug therapy of neurodegenerative diseases. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27(2): 303–321.
   PubMed Web of Science ®Google Scholar